01/17/2017 - 12:02pm

Carsten Brun will oversee the company’s pharmaceutical arm in the United States, Canada, Central and Latin America, reporting to pharmaceutical division president and board of management member Dieter Weinand. 

01/12/2017 - 1:08pm

The weekly Flu Index shows which populations are experiencing the most incidences of influenza each week based on Index methodology and does not measure actual levels or severity of flu activity, Walgreens noted.

01/11/2017 - 12:00pm

Mayne Pharma acquired the products from GSK in August 2016, and they complement the company’s Doryx, the first branded product in its specialty brands division that it launched in 2015. 

01/10/2017 - 1:56pm

The drug is indicated for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis or emphysema. 

01/10/2017 - 1:15pm

Egalet said Arymo ER is the first drug approved using its proprietary Guardian Technology, which works to deter abuse and prevent the tablets from being manipulated for abuse or misuse. 

01/09/2017 - 1:19pm

Johnson and Johnson worldwide chairman, pharmaceuticals, Joaquin  Duato will be the next board chairman of PhRMA. 

01/06/2017 - 2:15pm

The number of drugs the FDA approved last year, 22, is less than half of the 45 approved in 2015 and lower than the average of the last 10 years of approvals, which is 29. 

01/06/2017 - 12:57pm
This is the fifth approved indication for Lucentis. 
01/06/2017 - 12:21pm

U.S. District Court Judge Sue Robinson on Thursday issued an injunction on the sale of Praluent, a PCSK9 inhibitor from Sanofi and Regeneron. Amgen, maker of another PCSK9 inhibitor Repatha, filed the request for the injunction in 2016.